We offer free accommodation to our delegates with accepted oral presentation only.
Other delegates and guests including those with accepted poster presentations can avail accommodation in Zawia Jewel Hotel by paying US $ 750 for 3 days including all meals.
Poster Preparation Guidelines
The poster sessions will be held in the same area as the oral session halls to encourage extended dialogues.
Schedule:
Set-up time:
Saturday, May 22nd 0830-1800 Hrs and remove by Sunday, May 23rd 1400 Hrs.
Interaction time:
Sunday, May 23rd 0955 – 1040 Hrs
Size:
Poster boards will be placed horizontally and measure approximately 48 inches high by 36 inches wide (120 cm x 90 cm). The board is elevated on a stand in a way that the bottom of the board is approximately 12 inches (30 cm) off the ground. Sticking tape/pins will be made available.
Collection of materials at the end of the session is your responsibility. Posters not removed by the specified time will not be saved.
Preparation Suggestions
Title of your poster may appear at the top in large letters. Poster titles using a font size of 60 point will stand out and be easy to read. The minimum font size for poster titles should be 36 point. Below the title you may wish to put the author name(s) and affiliation(s). People will not read a lot of text, and certainly won’t read small-sized text. Try to use an easy-to-read font and keep the font size of important points to 24 – 40 point if possible. The smallest text on your poster should be at least 18 point. Studies show that text written in all capital letters is hard to follow; it is better to use bold print than all caps, though you must then make those bold-type statements stand out from the rest of your text.
Carefully and completely prepare your poster in advance of the conference. Try tacking up the poster before you leave for the meeting to see what it will look like and to make sure that you have all of the necessary pieces. The flow of your poster should be from the top left to the bottom right. You may wish to use color for highlighting and to make your poster more attractive. Use pictures, diagrams, cartoons, figures, etc., rather than text wherever possible. Use of color in your graphics will enhance your poster. Your art, graphics, or communications/media department may be very helpful in the preparation of your poster. Try to state your main result in large lettering allowing people to read the focus of the poster from a distance.
The poster must cover the key points of your work. It need not attempt to include all the details; you can describe them to people who are interested. The ideal poster is designed to attract attention, provide a brief overview of your work, and initiate discussion.
Workshops (for nurses):
22nd May 2010, Saturday
0930 – 1030: Handling of chemotherapy drugs
1100 – 1230: Infection control
Final Program
21st May 2010, Friday
1630 – 1800: Sponsored Lecture
1800: Opening Ceremony
Welcome address
22nd May 2010, Saturday
Meet the Expert: 0700 – 0800: Lymphoma
Session I: Lymphomas (0800 – 1020)
| Date | Time | Topic | Speaker |
| 22nd May 2010 | 0800 – 0815 | Usefulness and limitation of FNAC and Cytometry for NHL | M Brahimi |
| 0815 – 0830 | Prognostic factors and evaluation of the answer to protocols CHOP or R-CHOP of the diffuse large B-cell lymphoma of the young subject ≤ 60 years | SE Belakehal | |
| 0830 – 0845 | Aspects clinique et histologique des lymphomes malins non Hodgkiniens | S Dechir | |
| 0845 – 0900 | Tunisian experience in aggressive non-Hodgkin lymphoma | Laatiri Med Adnene | |
| 0900 – 0915 | Age and Autologous Stem Cell Transplantation | Asad Omran | |
| 0915 – 0930 | Mediastinal Localization of non-Hodgkin Lymphoma: Diagnostic therapeutic and prognostic approach | C. Aboura | |
| 0930 – 0945 | Hodgkin lymphoma in Tunisian patients : results from adult prospective multicenter hodgkin lymphoma studies ( MDH 2002 /2008 | Ben Lakhal Raihan | |
| 0945 – 1000 | Discussion | ||
Coffee Break: 1000 – 1040
Session II: Leukemias (1040 – 1325)
| Date | Time | Topic | Speaker |
| 22nd May 2010 | 1040 – 1055 | Conventional and molecular cytogenetic (FISH) for assessing diagnosis and prognosis of hematologic malignancies | S Taoussi |
| 1055 – 1110 | Cytogenetics aspects of Acute Myeloblastic Leukaemia in adults in Morocco | M Lamchahab | |
| 1110 – 1125 | Aspects Clinique, Biologique Et Therapeutique Des Leucemies Aigues Myeloblastiques Chez l’adulte | N Dali | |
| 1125 – 1140 | AML | Bacigulapo | |
| 1140 – 1155 | Management of Acute Myeloblastic Leukaemia in adults: Moroccan experience | A.Quessar | |
| 1155 – 1210 | Management of young AML patients in Aziza Othmana hospital | Ben Amor Ramzi | |
| 1210 – 1225 | Aspects Clinique biologique et therapeutique Des leucemies aigues lymphoblastiques de l’adulte | K Ait-Seddik | |
| 1225 – 1240 | Outcomes of CML patients : a Tunisian experience | Ben Amor Ramzi | |
| 1240 – 1255 | New treatments for fit and unfit patients with CLL | Marco Gobbi | |
| 1255 – 1310 | Discussion | ||
1310 – 1410: Sponsored Lecture
Lunch Break: 1410
Session III: Myeloma (1600 – 1830)
| Date | Time | Topic | Speaker |
| 22nd May 2010 | 1600 – 1620 | Management of multiple myeloma | Moulod EL-Agnaf |
| 1620 – 1640 | Treatment of MM in department of Hematology and BMT | A Arabi | |
| 1640 – 1700 | Preliminary results of Bortizomib–Dexamethazone protocol followed by therapeutic intensification by Melphalan 200 and autologous stem cell transplant in multiple myeloma | N Yafour | |
| 1700 – 1740 | Rétrospective evaluation of myeloma patient treated at the centre national de greffe de moelle de Tunis | Lakhal Amel | |
| 1740 – 1800 | Prevalance of JAK-V617 mutation in Algerian patients with myeloproliferative disorderAnalyse cytologique et immunochimique de 40 cas de myélome multiple à chaînes légères = Cytological and immunochemical analysis of 40 cases of light chain multiple myeloma | M C Rahali | |
| 1800 – 1815 | Discussion | ||
Dinner: 2030
23rd May 2010, Sunday
Meet the Expert: 0700 – 0800: Leukemias
Session I: Pediatric Hematology (0800 – 1020)
| Date | Time | Topic | Speaker |
| 23rd May 2010 | 0800 – 0820 | Haematological malignancies in Benghazi in the year 2009 | Mohamed Lateiwish |
| 0820 – 0840 | Descriptive study of series of 104 patients affected by haemophilia. | N saidane | |
| 0840 – 0900 | Management of AML in children: Moroccan experience | S.Cherkaoui | |
| 0900 – 0920 | Burkitt’s Lymphoma in children | H.Driouchi | |
| 0920 – 0940 | ITP | Ramdan Allous | |
| 0940 – 0955 | Discussion | ||
Session II: Poster Session (0955 – 1040)
Coffee Break: 1040 – 1100
Session III: Transfusion Medicine and Transplantation (1100 – 1330)
| Date | Time | Topic | Speaker |
| 23rd May 2010 | 1100 – 1115 | Transplantation for MM | Nuri Hwaje |
| 1115 – 1130 | Bone marrow transplant | Prof. Andrea Bachigulapo | |
| 1130 – 1145 | High-dose chemotherapy and HSCT for poor prognosis HL | M A Bekadja | |
| 1145 – 1200 | Libyan Experience in BMT | Nubila Sassi | |
| 1200 – 1215 | Allogeneic hematopoietic stem cell transplantation for 37 patients with Fanconi anemia | R Ahmed Nacer | |
| 1215 – 1230 | Evaluation of patients with Myelodysplastic Syndromes. A retrospective study | S.Bougherira | |
| 1230 – 1245 | Using computers to improve donor management and transfusion safety | Ktari Kamel | |
| 1245 – 1300 | الإجراءات الوقائية لنقل الدم (Arabic ) | Jalel Gargouri | |
| 1300 – 1315 | Discussion | ||
1315 – Closing Ceremony
Lunch: 1415
7th Maghrebian Hematology ConferenceLAAC & AOI organise the 7th Magharebian Congress of Hematology.
Topics:
Date: 21-23. May. 2010
Place: Zawia Jewel Hotel, Zawia
Expect the Un-expected
The aim of this study is to evaluate the occurrence of synchronous and metachronous malignant tumors in Libyan patients seen at African Oncology institute Sabratha Libya from February 2003 to August 2009 (78 months). The secondary aims was to analyze the data to find the tumor types seen most frequently, the age group, and relationship to treatment received.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo conseqduat. More…
Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo conseqduat. More…
Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo conseqduat. More…
Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo conseqduat. More…
